Growing Prevalence Of Lifestyle Oriented Diseases Across The Globe Fuelling The Growth In Protein Engineering Market

According to a recently published report, the Protein Engineering Market has been expected to grow by16.1% CAGR during 2016-2022. The segmentation of global protein engineering market is based on product, protein type, technology, end user and geography. The report on global protein engineering market forecast 2016-2022 (by product, protein type, technology, end user and geography) provides detailed overview and predictive analysis of the market.


Full report is available on global Protein Engineering market forecast 2016-2022 (by product, protein type, technology, end user and geography) report at http://www.briskinsights.com/report/protein-engineering-market


Growing prevalence of lifestyle oriented diseases across the globe and decrease in the cost for drug discovery is driving the global protein engineering market. According to WHO, about 235 million people have been suffering from asthma, moreover, the increasing cardiovascular diseases is also one of the major disease which is increasing due to changing life style and rising smoking habits across the globe. WHO estimated that 9.4 million deaths occurs each year due to cardiovascular diseases. High blood pressure is a crucial disease, increasing the demand for protein engineering market. Out of 9.4 million death around 17% are caused due to high blood pressure. However, the market is growing by various factors, there are some factors restraining the growthsuch as high cost of protein engineering and need of high maintenance. Protein therapy is emerging as a substitute to gene therapy and rising number of off-patents of biological drugs during theforecasted period are the key opportunities available in the global market. Moreover, there are some challenges such as lack of professional, qualified researchers and high training cost to protein engineering has been expected to hamper the growth of the global protein engineering market.


SCOPE OF THE REPORT

1. GLOBAL PROTEIN ENGINEERING MARKET BY TECHNOLOGY 2012-2022 ($ million)
1.1. Irrational Protein Design
1.2. Rational Protein Design


2. GLOBAL PROTEIN ENGINEERING MARKET BY END USER 2012-2022 ($ million)
2.1. Academic Research Institutes
2.2. Contract Research Organizations
2.3. Pharmaceutical & Biotechnology Companies


3. GLOBAL PROTEIN ENGINEERING MARKET BY PRODUCT 2012-2022 ($ million)
3.1. Instruments
3.2. Reagents
3.3. Services & Software


4. GLOBAL PROTEIN ENGINEERING MARKET BY PROTIEN TYPE 2012-2022 ($ million)
4.1. Coagulation Factor
4.2. Colony Stimulating Factor
4.3. Erythropoietin
4.4. Growth Hormones
4.5. Insulin
4.6. Interferon
4.7. Monoclonal Antibodies
4.8. Vaccines
4.9. Others


5. GLOBAL PROTEIN ENGINEERING MARKET REGIONAL OUTLOOK 2012-2022($million)
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Middle East & Africa
5.5. Latin America


6. COMPANY PROFILES
6.1. Ab Sciex
6.2. Agilent Technologies, Inc.
6.3. Bio-Rad Laboratories, Inc.
6.4. Bruker Corporation
6.5. Danaher Corporation
6.6. Eli Lilly And Company
6.7. Genentech Inc.
6.8. General Electric
6.9. Genscripts USA, Inc.
6.10. Johnson And Johnson
6.11. Novo Nordisk
6.12. PerkinElmer, Inc.
6.13. Sigma-Aldrich Corporation
6.14. Thermo Fisher Scientific
6.15. Waters Corporation